Neuroprotective Products Market
Neuroprotective Products Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Neuroprotective Products Market Size and Growth
The global neuroprotective products market is projected to reach USD 15.6 billion by 2025, with a CAGR of 7.4%. Growing prevalence of neurological disorders, increasing R&D investments, and rising geriatric population are driving market growth. Key players include Biogen, Novartis, and Sanofi. Innovation and technological advancements are expected to shape the market's future.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Genervon
◍ NeuroVive Pharmaceutical
◍ Ceregene
◍ BHR Pharma
◍ Neuren Pharmaceuticals
◍ Allon therapeutics
◍ Bionure
The competitive landscape of the Neuroprotective Products Market includes companies such as Genervon, NeuroVive Pharmaceutical, Ceregene, BHR Pharma, Neuren Pharmaceuticals, Allon Therapeutics, and Bionure. These companies develop and market neuroprotective drugs to treat various neurological disorders, contributing to the growth of the market.
- Genervon: $10.3 million
- Neuren Pharmaceuticals: $4.8 million
- NeuroVive Pharmaceutical: $3.6 million
Request Sample Report
Market Segmentation
By Application
Alzheimers disease
Multiple sclerosis
Request Sample Report
By Product
Cholinesterase inhibitors
NMDA receptor antagonists
Market Growth
Request Sample Report
$ X Billion USD
